Literature DB >> 32255719

The Genomics and Genetics of Oxygen Homeostasis.

Gregg L Semenza1.   

Abstract

Human survival is dependent upon the continuous delivery of O2 to each cell in the body in sufficient amounts to meet metabolic requirements, primarily for ATP generation by oxidative phosphorylation. Hypoxia-inducible factors (HIFs) regulate the transcription of thousands of genes to balance O2 supply and demand. The HIFs are negatively regulated by O2-dependent hydrox-ylation and ubiquitination by prolyl hydroxylase domain (PHD) proteins and the von Hippel-Lindau (VHL) protein. Germline mutations in the genes encoding VHL, HIF-2α, and PHD2 cause hereditary erythrocytosis, which is characterized by polycythemia and pulmonary hypertension and is caused by increased HIF activity. Evolutionary adaptation to life at high altitude is associated with unique genetic variants in the genes encoding HIF-2α and PHD2 that blunt the erythropoietic and pulmonary vascular responses to hypoxia.

Entities:  

Keywords:  Tibetan highlanders; congenital polycythemia; hereditary erythrocytosis; hypoxia-inducible factor

Mesh:

Substances:

Year:  2020        PMID: 32255719     DOI: 10.1146/annurev-genom-111119-073356

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  25 in total

1.  Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease.

Authors:  Volker H Haase
Journal:  Kidney Int Suppl (2011)       Date:  2021-03-18

Review 2.  The Functional Roles and Regulation of Circular RNAs during Cellular Stresses.

Authors:  Yueh-Chun Lee; Wei-Yu Wang; Hui-Hsuan Lin; Yi-Ren Huang; Ya-Chi Lin; Kuei-Yang Hsiao
Journal:  Noncoding RNA       Date:  2022-05-27

3.  ID2 and HIF-1α collaborate to protect quiescent hematopoietic stem cells from activation, differentiation, and exhaustion.

Authors:  Brad L Jakubison; Tanmoy Sarkar; Kristbjorn O Gudmundsson; Shweta Singh; Lei Sun; Holly M Morris; Kimberly D Klarmann; Jonathan R Keller
Journal:  J Clin Invest       Date:  2022-07-01       Impact factor: 19.456

4.  Differential HIF2α Protein Expression in Human Carotid Body and Adrenal Medulla under Physiologic and Tumorigenic Conditions.

Authors:  Lucía Celada; Tamara Cubiella; Jaime San-Juan-Guardado; Andrés San José Martínez; Nuria Valdés; Paula Jiménez-Fonseca; Ignacio Díaz; Jose María Enguita; Aurora Astudillo; Enol Álvarez-González; Luisa María Sierra; María-Dolores Chiara
Journal:  Cancers (Basel)       Date:  2022-06-17       Impact factor: 6.575

5.  Olfactory receptor 78 regulates erythropoietin and cardiorespiratory responses to hypobaric hypoxia.

Authors:  Benjamin Wang; Ying-Jie Peng; Xiaoyu Su; Chongxu Zhang; Jason S Nagati; Joseph A Garcia; Nanduri R Prabhakar
Journal:  J Appl Physiol (1985)       Date:  2021-02-04

Review 6.  Mechanisms of cellular iron sensing, regulation of erythropoiesis and mitochondrial iron utilization.

Authors:  Nunziata Maio; De-Liang Zhang; Manik C Ghosh; Anshika Jain; Anna M SantaMaria; Tracey A Rouault
Journal:  Semin Hematol       Date:  2021-06-27       Impact factor: 3.754

7.  Therapeutic inhibition of HIF-2α reverses polycythemia and pulmonary hypertension in murine models of human diseases.

Authors:  Manik C Ghosh; De-Liang Zhang; Wade H Ollivierre; Audrey Noguchi; Danielle A Springer; W Marston Linehan; Tracey A Rouault
Journal:  Blood       Date:  2021-05-06       Impact factor: 25.476

Review 8.  Molecular Crosstalk Between MYC and HIF in Cancer.

Authors:  Yanping Li; Xiao-Xin Sun; David Z Qian; Mu-Shui Dai
Journal:  Front Cell Dev Biol       Date:  2020-11-05

9.  Seq-ing Higher Ground: Functional Investigation of Adaptive Variation Associated With High-Altitude Adaptation.

Authors:  James E Hall; Elijah S Lawrence; Tatum S Simonson; Keolu Fox
Journal:  Front Genet       Date:  2020-05-14       Impact factor: 4.772

Review 10.  The Role of Sumoylation in the Response to Hypoxia: An Overview.

Authors:  Chrysa Filippopoulou; George Simos; Georgia Chachami
Journal:  Cells       Date:  2020-10-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.